Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijrobp.2012.04.043PMID 22682812PMCID PMC3448004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity.

  2011cited by this paper
• Predictive factors for symptomatic radiation pneumonitis in 293 consecutively treated non-small cell lung cancer (NSCLC) patients receiving definitive radiation therapy.

  2011cited by this paper
• A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer.

  2011cited by this paper
• Clinical and Technical Assessment of Respiratory Gated Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer

  2011cited by this paper
• Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.

  2010cited by this paper
• Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.

  2010cited by this paper
• Radiation dose-volume effects in the lung.

  2010cited by this paper
• A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117.

  2010cited by this paper
• Chemotherapy Significantly Increases the Risk of Radiation Pneumonitis in Radiation Therapy of Advanced Lung Cancer

  2010cited by this paper
• Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.

  2010cited by this paper
• A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.

  2007cited by this paper
• The impact of induction chemotherapy and the associated tumor response on subsequent radiation-related changes in lung function and tumor response.

  2007cited by this paper
• Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.

  2007cited by this paper
• Predictive factors for radiation-induced pulmonary toxicity after three-dimensional conformal chemoradiation in locally advanced non-small-cell lung cancer

  2007cited by this paper
• Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer

  2005cited by this paper
• Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.

  2005cited by this paper
• Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.

  2004cited by this paper
• Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.

  2003cited by this paper
• Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.

  2003cited by this paper

• Radiotherapy plus immune checkpoint inhibitors versus immune checkpoint inhibitors alone for non-small cell lung cancer with bone metastases: a systematic review and meta-analysis of comparative cohort studies.

  2026cites this paper
• 4D-CT strain analysis for biomechanical characterization of COPD in patients undergoing radiotherapy planning: an exploratory study

  2026cites this paper
• Improving the Prediction of Radiation Pneumonitis: Leveraging Radiomics and Dosiomics Within IDLSS Lung Subregions.

  2026cites this paper
• Simultaneous synthesis of perfusion and ventilation images from CT using a dual-decoder residual attention network for lung disease diagnosis.

  2026cites this paper
• A novel accumulative modelling method using temporal images: Concept proposal and clinical validation on multiple diseases.

  2026cites this paper
• Prediction of Symptomatic Radiation Pneumonitis in Lung Cancer Patients: A Radiomics and Dosiomics Machine Learning Approach Using the Prospective Multicenter RTOG 0617 and REQUITE trials.

  2026cites this paper
• Wildfire smoke exposure and radiation oncology outcomes in rural Manitoba lung cancer patients: a systematic review

  2026cites this paper
• Integrated machine learning risk model for predicting radiation pneumonitis in lung cancer patients with interstitial lung disease.

  2026cites this paper
• Assessing Radiation Pneumonitis Through Functional Lung Imaging: A Single Photon Emission Computed Tomography (SPECT)-Based Approach in Lung Cancer.

  2026influential citation
• A Radiomics-Based Machine Learning Model for Predicting Pneumonitis During Durvalumab Treatment in Locally Advanced NSCLC

  2026cites this paper
• A Bayesian framework for the detection of physiological pulmonary ventilation changes

  2026cites this paper
• Immune Checkpoint Inhibitor-associated Pneumonitis: A Narrative Review

  2025cites this paper
• Predicting Severe Radiation Pneumonitis in Patients With Locally-Advanced Non-Small-Cell Lung Cancer After Thoracic Radiotherapy: Development and Validation of a Nomogram Based on the Clinical, Hematological, and Dose-Volume Histogram Parameters.

  2025cites this paper
• Association between dose to cardiac structures and overall survival: A multivariable analysis in a large, multi-institutional database of stage III NSCLC patients with external validation.

  2025cites this paper
• Multimodal data deep learning method for predicting symptomatic pneumonitis caused by lung cancer radiotherapy combined with immunotherapy

  2025cites this paper
• Segmental bronchi radiation dose affected the progression of radiation pneumonitis in lung cancer patients

  2025cites this paper
• Detecting Biomarkers of Radiation Pneumonitis in Exhaled Breath During Chemoradiotherapy for Stage III Non-small Cell Lung Cancer: Results of a Prospective Feasibility Study

  2025cites this paper
• A machine learning approach for radiation pneumonitis prediction in elderly esophageal cancer patients by integrating baseline computed tomography radiomics, dosiomics, and clinical characteristics

  2025cites this paper
• Expert consensus on cancer treatment-related lung injury

  2025cites this paper
• European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer

  2025cites this paper
• Anatomical Parameter-driven Volumetric Modulated Arc Therapy Optimization in Left-sided Breast Cancer: A Machine Learning Framework for Lung Dose Prediction

  2025cites this paper
• PNA-FISH-based Chromosome Aberration Frequency and Serum IL-6 as Predictive Biomarkers for Radiation Therapy-induced Pneumonitis in Lung Cancer Patients.

  2025cites this paper
• Risk factors for pneumonitis after the combination treatment of immune checkpoint inhibitors and thoracic radiotherapy

  2025cites this paper
• Pulmonary Complications of Lung Cancer and Cancer Therapy: Manifestations and Management

  2025cites this paper
• Risk Factors for Radiation Pneumonitis and a Prognostic Instrument for Very Elderly Patients With Lung Cancer

  2025cites this paper
• AFSOS-SFRO Guidelines on Radiation-Induced Lung Injury.

  2025cites this paper
• Association Between Lung Volume Reduction and Symptomatic Radiation Pneumonitis in Lung Cancer Patients Undergoing Definitive Concurrent Chemoradiotherapy.

  2025cites this paper
• Prediction model developed on the basis of meta-analysis in the field of medicine: a systematic survey and methodological summaries

  2025cites this paper
• Benefit of Consolidation Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer Patients Treated with Immunotherapy: Data from Slovenian Cohort

  2025cites this paper
• A Review of Radiation Induced Lung Injury in Elderly Patients

  2025cites this paper
• Predicting radiation pneumonitis with dose-segmented radiomics in locally advanced non- small cell lung cancer patients undergoing consolidative immunotherapy post- concurrent chemoradiotherapy

  2025cites this paper
• Thymus Composition Predicts Pneumonitis Risk in Lung Cancer Therapy

  2025cites this paper
• Overexpression of METTL3 in lung cancer cells inhibits radiation-induced bystander effect.

  2025cites this paper
• Development of a Scoring Instrument for Identification of Pneumonitis in Older Lung Cancer Patients After Radiotherapy (POLCAR): A Protocol for a Prospective Trial

  2025cites this paper
• Pneumonitis after chemoradiation followed by durvalumab for locally advanced lung cancer, predictors and effect on survival.

  2025cites this paper
• [Recommendations on the prevention and management of radiation-induced lung injury from the Association francophone pour les soins oncologiques de support and the Société française de radiothérapie oncologique].

  2025cites this paper
• Reducing radiation pneumonitis in lung cancer patients: from Chinese expert consensus to practice

  2025influential citation
• A Dual Radiomic and Dosiomic Filtering Technique for Locoregional Radiation Pneumonitis Prediction in Breast Cancer Patients

  2025cites this paper
• Use of NTCP metrics to identify unbalanced levels of dose trade‐off between left lung and heart in lung cancer radiotherapy

  2025cites this paper
• Association of artificial intelligence-screened interstitial lung disease with radiation pneumonitis in locally advanced non-small cell lung cancer.

  2025cites this paper
• A prospective pilot study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer.

  2025cites this paper
• European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.

  2025cites this paper
• The risk of symptomatic radiation pneumonitis in small cell lung cancer patients following sequential immunochemotherapy and radiotherapy: a multicenter retrospective cohort study

  2025cites this paper
• Estimating the Risk of Radiation Pneumonitis in Elderly Patients With Lung Cancer

  2025cites this paper
• The effect of durvalumab consolidation after definitive radiochemotherapy for non-operable stage III non-small cell lung cancer on the dose effect relation for therapy related pulmonary infiltrates as a risk factor for pneumonitis

  2025cites this paper
• Predictive value of machine learning for radiation pneumonitis and checkpoint inhibitor pneumonitis in lung cancer patients: a systematic review and meta-analysis

  2025cites this paper
• Multicenter development of a deep learning radiomics and dosiomics nomogram to predict radiation pneumonia risk in non-small cell lung cancer

  2025cites this paper
• Targeting the CXCL12/CXCR4 pathway to reduce radiation treatment side effects.

  2024cites this paper
• Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials.

  2024cites this paper
• Properties of [18F]FAPI monitoring of acute radiation pneumonia versus [18F]FDG in mouse models

  2024cites this paper
• Research on Developing a Predictive Model for Radiation Pneumonitis Risk Based on Radiomics and Multiparameters

  2024cites this paper
• Computed tomography patterns and clinical outcomes of radiation pneumonitis in non–small-cell lung cancer patients

  2024influential citation
• Consolidation Radiotherapy in M1a Non-small Cell Lung Cancer Yields Equivalent Outcomes as Locally Advanced Disease

  2024cites this paper
• Synergizing the interaction of single nucleotide polymorphisms with dosiomics features to build a dual-omics model for the prediction of radiation pneumonitis.

  2024cites this paper
• Pathogenic mechanisms and latest therapeutic approaches for radiation-induced lung injury: a narrative review.

  2024cites this paper
• Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process

  2024influential citation
• Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer

  2024cites this paper
• Definitive chemoradiotherapy with Carboplatin Plus Paclitaxel for Unresectable Locally Advanced Thymic Carcinoma: A case series

  2024cites this paper
• A retrospective comparison of induction chemoimmunotherapy versus chemotherapy followed by concurrent chemoradiotherapy and consolidation immunotherapy in stage III non-small cell lung cancer

  2024cites this paper
• Assessment of radiation pneumonitis and predictive factors in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

  2024influential citation
• CT-based different regions of interest radiomics analysis for acute radiation pneumonitis in patients with locally advanced NSCLC after chemoradiotherapy

  2024cites this paper
• Clinical predictors of severe radiation pneumonitis in patients undergoing thoracic radiotherapy for lung cancer

  2024cites this paper
• Multitemporal single‐cell profiling decoding crosstalk between γδ17 T cells and neutrophils in radiation pneumonitis

  2024cites this paper
• Dosimetric comparison of nodal clinical target volume for locally advanced non‑small cell lung cancer: Options for geometric expansion vs. lymph node stations

  2024influential citation
• Incorporation of Functional Lung Imaging Into Radiation Therapy Planning in Patients With Lung Cancer: A Systematic Review and Meta-Analysis

  2024cites this paper
• Timing of Radiation Pneumonitis in Patients with Stage 3 Non-Small-Cell Lung Cancer Receiving Consolidation Durvalumab after Chemoradiation

  2024influential citation
• Early Mortality After Curative-intent Radiotherapy in Patients With Locally Advanced Non-small Cell Lung Cancer-A Population-based Cohort Study.

  2024cites this paper
• Evaluation of Radiation Pneumonitis in a Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer (NSCLC): Big Ten Cancer Research Consortium BTCRC-LUN16-081.

  2024cites this paper
• Optimal management of radiation pneumonitis: Findings of an international Delphi consensus study.

  2024cites this paper
• Mechanistic model of radiotherapy-induced lung fibrosis using coupled 3D agent-based and Monte Carlo simulations

  2024cites this paper
• Stereotactic Radiation Therapy in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Nonrandomized Clinical Trial.

  2024cites this paper
• A dynamic nomogram predicting symptomatic pneumonia in patients with lung cancer receiving thoracic radiation

  2024cites this paper
• Impact of the neutrophil-to-lymphocyte ratio on patients with locally advanced non-small cell lung cancer who suffer radiation pneumonitis during the course of induction chemoradiotherapy followed by surgery

  2024cites this paper
• A Phase 2 Randomized Clinical Trial Evaluating 4DCT Ventilation-based Functional Lung Avoidance Radiotherapy for Non-Small Cell Lung Cancer.

  2024cites this paper
• Quantifying regional radiation-induced lung injury in patients using hyperpolarized xenon-129 gas exchange magnetic resonance imaging.: Assessing RT lung injury with HP-xenon GX MRI.

  2024cites this paper
• Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy

  2024cites this paper
• Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.

  2024cites this paper
• Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receiving radiotherapy: a retrospective multi-center radiogenomics study

  2024influential citation
• The predictive role of baseline pulmonary function test in lung carcinoma patients for radiation-induced lung toxicity treated with conformal radiation therapy.

  2024cites this paper
• Characterisation of quantitative imaging biomarkers for inflammatory and fibrotic radiation-induced lung injuries using preclinical radiomics.

  2024cites this paper
• TMT-based proteomic analysis of radiation lung injury in rats

  2024influential citation
• CT ventilation images produced by a 3D neural network show improvement over the Jacobian and HU DIR-based methods to predict quantized lung function.

  2024cites this paper
• Dosimetric Predictors of Acute Radiation Pneumonitis and Esophagitis in Hypofractionated Thoracic Irradiation of Non-Small Cell Lung Cancer Patients With Poor Prognostic Factors

  2024cites this paper
• Clinical, Dosimetric and Radiomic Features Predictive of Lung Toxicity After (Chemo)Radiotherapy.

  2024cites this paper
• From pixels to prognosis: unveiling radiomics models with SHAP and LIME for enhanced interpretability

  2024cites this paper
• Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer.

  2024cites this paper
• Impact of Normal Lung Volume Choices on Radiation Pneumonitis Risk Prediction in Locally Non-small Cell Lung Cancer Radiation Therapy

  2024cites this paper
• A review on functional lung avoidance radiotherapy plan for lung cancer

  2024cites this paper
• Single isocenter versus dual isocenter treatment using flattening filter‐free and jaw‐tracking volumetrically modulated arc therapy for boot‐shaped lung cancer: Evaluation of dosimetric and feasibility

  2024cites this paper
• The radiotherapy planning CT-based multi-omics for predicting the radiation pneumonitis in lung cancer patients: A multi-center study

  2023cites this paper
• Evaluating the Necessity of Adaptive RT and the Role of Deformable Image Registration in Lung Cancer with Different Pathologic Classifications

  2023cites this paper
• Ipsilateral lung dose as a correlative measure for radiation pneumonitis in patients treated with definitive concurrent radiochemotherapy

  2023cites this paper
• Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer.

  2023cites this paper
• Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy.

  2023cites this paper
• Analysis of clinical and physical dosimetric factors that determine the outcome of severe acute radiation pneumonitis in lung cancer patients

  2023influential citation
• Pneumonitis rates before and after adoption of immunotherapy consolidation in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiation.

  2023cites this paper
• UCHL1 Regulates Radiation Lung Injury via Sphingosine Kinase-1

  2023influential citation
• Optimal timing for local ablative treatment of bone oligometastases in non-small cell lung cancer

  2023cites this paper
• Radiation Pneumonitis, Really? A Case of Pulmonary Toxicity from CDK4/6 Inhibitor

  2023cites this paper
• Compound Kushen Injection Reduces Severe Toxicity and Symptom Burden Associated With Curative Radiotherapy in Patients With Lung Cancer.

  2023cites this paper